Matches in SemOpenAlex for { <https://semopenalex.org/authorship/W2528973931A5010058034> ?p ?o ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- W2528973931A5010058034 type Authorship @default.
- W2528973931A5010058034 hasAuthor A5010058034 @default.
- W2528973931A5010058034 hasOrganization I123044942 @default.
- W2528973931A5010058034 hasOrganization I1286438233 @default.
- W2528973931A5010058034 hasOrganization I1320351128 @default.
- W2528973931A5010058034 hasOrganization I2802050225 @default.
- W2528973931A5010058034 hasOrganization I4210087039 @default.
- W2528973931A5010058034 hasOrganization I4210114363 @default.
- W2528973931A5010058034 hasOrganization I4210153460 @default.
- W2528973931A5010058034 hasOrganization I71999127 @default.
- W2528973931A5010058034 isCorresponding "false" @default.
- W2528973931A5010058034 position "2" @default.
- W2528973931A5010058034 rawAffiliation "2015/027 and 2015/054), and Fulbright Program, Ministry of Education (grant PRX16/00147) Spain.; Accepted 6 July, 2016; Author contributions: research conception and design was contributed by DF, AS, JT, RM; Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, (DF, AS, PZ, JT, RM); Department of Internal Medicine, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat (FB); Municipal Center for Substance Abuse Treatment (Centro Delta), IMSP (IR); Received 22 March, 2016; The authors report no conflicts of interest.; The funding sources had no role in the design and conduct of the study; The study was supported by Ministry of Economy and Competitiveness, Institute of Health Carlos III, (RETICS RD 12/0028/0006 and RD16/0017/0003), European Fund for Regional Development (FEDER), Ministry of Health, Social Services and Equality (grants EC11-042, and National Plan on Drugs-PNSD 2014/042; collection of data, DF, FB, IR, RM; collection, management, analysis, and interpretation of the data; data analysis, DF, AS; decision to submit the manuscript for publication.; interpretation of results, DF, AS, IR, FB, PZ, JT, MF, RM; manuscript writing, DF, AS, RM; preparation, review, or approval of the manuscript; revision of the manuscript, DF, AS, IR, FB, PZ, MF, JT, RM. All authors have approved the final version of the article." @default.